Geistlich Pharma AG:企業の戦略的SWOT分析

◆英語タイトル:Geistlich Pharma AG - Strategic SWOT Analysis Review
◆商品コード:DATA904C15887
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Geistlich Pharma AG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Geistlich Pharma AG (Geistlich Pharma), a part of Geistlich Holding, develops, manufactures and markets biomaterials for the regeneration of bone, cartilage and tissue. The company offers dental products, including bone substitutes, matrices and membranes in various therapeutic areas such as extraction socket management, bone augmentation, sinus floor elevation, soft-tissue regeneration, peri-implantitis and periodontal treatment. Its major products include Geistlich Bio-Oss, a natural bone substitute; and Geistlich Bio-Gide, a collagen membrane for oral tissue regeneration. It offers orthopaedic products in various therapeutic areas such as bone substitutes and cartilage regeneration. Geistlich Pharma also offers dietary supplements, infectiology and dermatology products. The company markets products through distribution partners and affiliates in Europe, Asia, South America and North America. Geistlich Pharma is headquartered in Wolhusen, Switzerland.

Geistlich Pharma AG Key Recent Developments

Mar 29,2018 Geistlich: Investment In Wolhusen Site

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Geistlich Pharma AG – Key Facts
Geistlich Pharma AG – Key Employees
Geistlich Pharma AG – Key Employee Biographies
Geistlich Pharma AG – Major Products and Services
Geistlich Pharma AG – History
Geistlich Pharma AG – Company Statement
Geistlich Pharma AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Geistlich Pharma AG – Business Description
Geistlich Pharma AG – SWOT Analysis
SWOT Analysis – Overview
Geistlich Pharma AG – Strengths
Geistlich Pharma AG – Weaknesses
Geistlich Pharma AG – Opportunities
Geistlich Pharma AG – Threats
Geistlich Pharma AG – Key Competitors
Section 3 – Company’s Recent Developments
Mar 29, 2018: Geistlich: Investment In Wolhusen Site
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Geistlich Pharma AG, Key Facts
Geistlich Pharma AG, Key Employees
Geistlich Pharma AG, Key Employee Biographies
Geistlich Pharma AG, Major Products and Services
Geistlich Pharma AG, History
Geistlich Pharma AG, Subsidiaries
Geistlich Pharma AG, Key Competitors

★海外企業調査レポート[Geistlich Pharma AG:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Four Seasons Hotels and Resorts:企業の戦略的SWOT分析
    Four Seasons Hotels and Resorts - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Emtec, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Emtec, Inc. Mergers and Acquisi …
  • Grainger plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Grainger plc Mergers and Acquis …
  • Fibrocell Science Inc (FCSC):医療機器:M&Aディール及び事業提携情報
    Summary Fibrocell Science Inc (Fibrocell Science) is an autologous cell and gene therapy company which discovers and develops therapies for diseases affecting the skin and connective tissue. The company’s product pipeline comprises FCX-007, a lead candidate for the treatment of recessive dystrophic …
  • POSCO Engineering and Construction Ltd.:企業の戦略・SWOT・財務分析
    SummaryPOSCO Engineering and Construction Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …
  • Medison Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Medison Co., Ltd. Mergers and A …
  • Onex Corporation:企業の戦略・SWOT・財務情報
    Onex Corporation - Strategy, SWOT and Corporate Finance Report Summary Onex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tat Hong Holdings Ltd.の企業概要及び財務/SWOT分析
    Tat Hong Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterl …
  • Bellco Srl:医療機器:M&Aディール及び事業提携情報
    Summary Bellco Srl (Bellco), a subsidiary of Medtronic plc, is a biotechnology company that offers hemodialysis solutions. The company provides chronic line, acute line and neonatal patient products. Its chronic line products comprise haemodiafiltration therapies and dialysis machines, among others. …
  • InMed Pharmaceuticals Inc (IN):企業財務及び戦略的SWOT分析
    Summary InMed Pharmaceuticals Inc (InMed) formerly Cannabis Technologies, Inc., develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets. The company pipeline products include INM-750 and INM-085. Its products are used for the treatment of glaucoma …
  • Exelixis, Inc.:企業のM&A・提携・投資分析
    Exelixis, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exelixis, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Copalis:企業の戦略・SWOT・財務情報
    Copalis - Strategy, SWOT and Corporate Finance Report Summary Copalis - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • CellCentric Ltd.(製薬・医療分野):企業M&A動向
    Summary CellCentric Ltd. (CellCentric) is a drug discovery company. The company manufactures and distributes drugs and small molecule inhibitors for cancer. Its programme concentrates on deubiquitinase (DUB) enzyme which associates with prostate cancer. The company’s programme has clinical utility i …
  • Imdex Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Imdex Limited Mergers and Acqui …
  • Histogen, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Histogen, Inc. (Histogen) is a pharmaceutical company. The company research, develops, manufactures and sells products using the proteins and growth factors manufactured by hypoxia-induced multipotent cells for therapeutic and biomedical applications. Its products include an insoluble human …
  • Semperit AG Holding (SEM):企業概要、財務及び戦略的SWOT分析
    Summary Semperit AG Holding (Semperit) is a medical device company. The company develops, produces, and sells specialized rubber and plastic products for the medical and industrial sectors. Its products include gloves, hydraulic hoses, industrial hoses, rubber sheeting, conveyor bels, building const …
  • Vostok New Ventures Ltd (VNIL SDB):企業の財務及び戦略的SWOT分析
    Summary Vostok New Ventures Ltd. (Vostok New Ventures), formerly Vostok Nafta Investment Ltd is an investment company that identifies and invests in assets with considerable potential for value appreciation. The company invests in the projects of oil, gas and mining industries and Russian consumer m …
  • Associated Banc-Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Associated Banc-Corp. Mergers a …
  • Cantab Biopharmaceuticals Limited (formerly Cambridge Biomanufacturing Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cantab Biopharmaceuticals Limit …
  • Gold Fields Ltd:戦略・SWOT・企業財務分析
    Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report Summary Gold Fields Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆